Canonical NF-κB Activity, Dispensable for B Cell Development, Replaces BAFF-Receptor Signals and Promotes B Cell Proliferation upon Activation

Immunity

Volumn 24, Issue 6, 2006, Pages 729-739

  Sasaki, Yoshiteru ^a   Derudder, Emmanuel ^a   Hobeika, Elias ^b   Pelanda, Roberta ^b   Reth, Michael ^b   Rajewsky, Klaus ^a   Schmidt Supprian, Marc ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b MAX PLANCK INSTITUTE OF IMMUNOBIOLOGY AND EPIGENETICS   (Germany)

Author keywords

MOLIMMUNO; SIGNALING

Indexed keywords

CELL SURFACE RECEPTOR; I KAPPA B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROTEIN BAFF; UNCLASSIFIED DRUG; B CELL ACTIVATING FACTOR RECEPTOR; CD19 ANTIGEN; I KAPPA B KINASE; MEMBRANE PROTEIN; PROTEIN KINASE C DELTA; TNFRSF13C PROTEIN, MOUSE; TUMOR NECROSIS FACTOR RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; B LYMPHOCYTE; CELL MATURATION; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; LYMPHOMA; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SURVIVAL; ACTIVE TRANSPORT; ANIMAL; B CELL LYMPHOMA; CELL NUCLEUS; ENZYMOLOGY; GENETICS; HYPERPLASIA; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; METABOLISM; MOUSE MUTANT; PATHOLOGY; PHYSIOLOGY; SPLEEN;

ACTIVE TRANSPORT, CELL NUCLEUS; ANIMALS; ANTIGENS, CD19; B-CELL ACTIVATION FACTOR RECEPTOR; B-LYMPHOCYTES; CELL NUCLEUS; CELL PROLIFERATION; HYPERPLASIA; I-KAPPA B KINASE; LYMPHOCYTE ACTIVATION; LYMPHOMA, B-CELL; MEMBRANE PROTEINS; MICE; MICE, MUTANT STRAINS; NF-KAPPA B; PROTEIN KINASE C-DELTA; RECEPTORS, TUMOR NECROSIS FACTOR; SPLEEN;

EID: 33744989924     PISSN: 10747613     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.immuni.2006.04.005     Document Type: Article

References (46)

1. Amanna I.J., Dingwall J.P., and Hayes C.E. Enforced bcl-xL gene expression restored splenic B lymphocyte development in BAFF-R mutant mice. J. Immunol. 170 (2003) 4593-4600
2. Anzelon A.N., Wu H., and Rickert R.C. Pten inactivation alters peripheral B lymphocyte fate and reconstitutes CD19 function. Nat. Immunol. 4 (2003) 287-294
3. Beinke S., and Ley S.C. Functions of NF-kappaB1 and NF-kappaB2 in immune cell biology. Biochem. J. 382 (2004) 393-409
4. Claudio E., Brown K., Park S., Wang H., and Siebenlist U. BAFF-induced NEMO-independent processing of NF-kappa B2 in maturing B cells. Nat. Immunol. 3 (2002) 958-965
5. Craxton A., Draves K.E., Gruppi A., and Clark E.A. BAFF regulates B cell survival by downregulating the BH3-only family member Bim via the ERK pathway. J. Exp. Med. 202 (2005) 1363-1374
6. Donahue A.C., and Fruman D.A. PI3K signaling controls cell fate at many points in B lymphocyte development and activation. Semin. Cell Dev. Biol. 15 (2004) 183-197
7. Engel P., Zhou L.J., Ord D.C., Sato S., Koller B., and Tedder T.F. Abnormal B lymphocyte development, activation, and differentiation in mice that lack or overexpress the CD19 signal transduction molecule. Immunity 3 (1995) 39-50
8. Gerondakis S., and Strasser A. The role of Rel/NF-kappaB transcription factors in B lymphocyte survival. Semin. Immunol. 15 (2003) 159-166
9. Gorelik L., Gilbride K., Dobles M., Kalled S.L., Zandman D., and Scott M.L. Normal B cell homeostasis requires B cell activation factor production by radiation-resistant cells. J. Exp. Med. 198 (2003) 937-945
10. Hara H., Wada T., Bakal C., Kozieradzki I., Suzuki S., Suzuki N., Nghiem M., Griffiths E.K., Krawczyk C., Bauer B., et al. The MAGUK family protein CARD11 is essential for lymphocyte activation. Immunity 18 (2003) 763-775
11. Hatada E.N., Do R.K., Orlofsky A., Liou H.C., Prystowsky M., MacLennan I.C., Caamano J., and Chen-Kiang S. NF-kappa B1 p50 is required for BLyS attenuation of apoptosis but dispensable for processing of NF-kappa B2 p100 to p52 in quiescent mature B cells. J. Immunol. 171 (2003) 761-768
12. Hayden M.S., and Ghosh S. Signaling to NF-kappaB. Genes Dev. 18 (2004) 2195-2224
13. He B., Chadburn A., Jou E., Schattner E.J., Knowles D.M., and Cerutti A. Lymphoma B cells evade apoptosis through the TNF family members BAFF/BLyS and APRIL. J. Immunol. 172 (2004) 3268-3279
14. Jun J.E., Wilson L.E., Vinuesa C.G., Lesage S., Blery M., Miosge L.A., Cook M.C., Kucharska E.M., Hara H., Penninger J.M., et al. Identifying the MAGUK protein Carma-1 as a central regulator of humoral immune responses and atopy by genome-wide mouse mutagenesis. Immunity 18 (2003) 751-762
15. Kaisho T., Takeda K., Tsujimura T., Kawai T., Nomura F., Terada N., and Akira S. IkappaB kinase alpha is essential for mature B cell development and function. J. Exp. Med. 193 (2001) 417-426
16. Karin M., Cao Y., Greten F.R., and Li Z.W. NF-kappaB in cancer: from innocent bystander to major culprit. Nat. Rev. Cancer 2 (2002) 301-310
17. Kern C., Cornuel J.F., Billard C., Tang R., Rouillard D., Stenou V., Defrance T., Ajchenbaum-Cymbalista F., Simonin P.Y., Feldblum S., and Kolb J.P. Involvement of BAFF and APRIL in the resistance to apoptosis of B-CLL through an autocrine pathway. Blood 103 (2004) 679-688
18. Kim S., La Motte-Mohs R.N., Rudolph D., Zuniga-Pflucker J.C., and Mak T.W. The role of nuclear factor-kappaB essential modulator (NEMO) in B cell development and survival. Proc. Natl. Acad. Sci. USA 100 (2003) 1203-1208
19. Kraus M., Alimzhanov M.B., Rajewsky N., and Rajewsky K. Survival of resting mature B lymphocytes depends on BCR signaling via the Igalpha/beta heterodimer. Cell 117 (2004) 787-800
20. Lam K.P., Kuhn R., and Rajewsky K. In vivo ablation of surface immunoglobulin on mature B cells by inducible gene targeting results in rapid cell death. Cell 90 (1997) 1073-1083
21. Mecklenbrauker I., Kalled S.L., Leitges M., Mackay F., and Tarakhovsky A. Regulation of B-cell survival by BAFF-dependent PKCdelta-mediated nuclear signalling. Nature 431 (2004) 456-461
22. Mercurio F., Zhu H., Murray B.W., Shevchenko A., Bennett B.L., Li J., Young D.B., Barbosa M., Mann M., Manning A., and Rao A. IKK-1 and IKK-2: cytokine-activated IkappaB kinases essential for NF-kappaB activation. Science 278 (1997) 860-866
23. Morrison M.D., Reiley W., Zhang M., and Sun S.C. An atypical tumor necrosis factor (TNF) receptor-associated factor-binding motif of B cell-activating factor belonging to the TNF family (BAFF) receptor mediates induction of the noncanonical NF-kappaB signaling pathway. J. Biol. Chem. 280 (2005) 10018-10024
24. Ng L.G., Mackay C.R., and Mackay F. The BAFF/APRIL system: life beyond B lymphocytes. Mol. Immunol. 42 (2005) 763-772
25. Novak A.J., Grote D.M., Stenson M., Ziesmer S.C., Witzig T.E., Habermann T.M., Harder B., Ristow K.M., Bram R.J., Jelinek D.F., et al. Expression of BLyS and its receptors in B-cell non-Hodgkin lymphoma: correlation with disease activity and patient outcome. Blood 104 (2004) 2247-2253
26. Otero D.C., Anzelon A.N., and Rickert R.C. CD19 function in early and late B cell development: I. Maintenance of follicular and marginal zone B cells requires CD19-dependent survival signals. J. Immunol. 170 (2003) 73-83
27. Pasparakis M., Schmidt-Supprian M., and Rajewsky K. IkappaB kinase signaling is essential for maintenance of mature B cells. J. Exp. Med. 196 (2002) 743-752
28. Pelletier M., Thompson J.S., Qian F., Bixler S.A., Gong D., Cachero T., Gilbride K., Day E., Zafari M., Benjamin C., et al. Comparison of soluble decoy IgG fusion proteins of BAFF-R and BCMA as antagonists for BAFF. J. Biol. Chem. 278 (2003) 33127-33133
29. Rahman Z.S., and Manser T. B cells expressing Bcl-2 and a signaling-impaired BAFF-specific receptor fail to mature and are deficient in the formation of lymphoid follicles and germinal centers. J. Immunol. 173 (2004) 6179-6188
30. Ramakrishnan P., Wang W., and Wallach D. Receptor-specific signaling for both the alternative and the canonical NF-kappaB activation pathways by NF-kappaB-inducing kinase. Immunity 21 (2004) 477-489
31. Rickert R.C., Rajewsky K., and Roes J. Impairment of T-cell-dependent B-cell responses and B-1 cell development in CD19-deficient mice. Nature 376 (1995) 352-355
32. Rosenwald A., and Staudt L.M. Gene expression profiling of diffuse large B-cell lymphoma. Leuk. Lymphoma 44 Suppl 3 (2003) S41-S47
33. Ruland J., Duncan G.S., Elia A., del Barco Barrantes I., Nguyen L., Plyte S., Millar D.G., Bouchard D., Wakeham A., Ohashi P.S., and Mak T.W. Bcl10 is a positive regulator of antigen receptor-induced activation of NF-kappaB and neural tube closure. Cell 104 (2001) 33-42
34. Sasaki Y., Casola S., Kutok J.L., Rajewsky K., and Schmidt-Supprian M. TNF family member B cell-activating factor (BAFF) receptor-dependent and -independent roles for BAFF in B cell physiology. J. Immunol. 173 (2004) 2245-2252
35. Schmidt-Supprian M., Bloch W., Courtois G., Addicks K., Israel A., Rajewsky K., and Pasparakis M. NEMO/IKK gamma-deficient mice model incontinentia pigmenti. Mol. Cell 5 (2000) 981-992
36. Senftleben U., Cao Y., Xiao G., Greten F.R., Krahn G., Bonizzi G., Chen Y., Hu Y., Fong A., Sun S.C., and Karin M. Activation by IKKalpha of a second, evolutionary conserved, NF-kappa B signaling pathway. Science 293 (2001) 1495-1499
37. Shulga-Morskaya S., Dobles M., Walsh M.E., Ng L.G., MacKay F., Rao S.P., Kalled S.L., and Scott M.L. B cell-activating factor belonging to the TNF family acts through separate receptors to support B cell survival and T cell-independent antibody formation. J. Immunol. 173 (2004) 2331-2341
38. Siebenlist U., Brown K., and Claudio E. Control of lymphocyte development by nuclear factor-kappaB. Nat. Rev. Immunol. 5 (2005) 435-445
39. Suzuki H., Matsuda S., Terauchi Y., Fujiwara M., Ohteki T., Asano T., Behrens T.W., Kouro T., Takatsu K., Kadowaki T., and Koyasu S. PI3K and Btk differentially regulate B cell antigen receptor-mediated signal transduction. Nat. Immunol. 4 (2003) 280-286
40. Tardivel A., Tinel A., Lens S., Steiner Q.G., Sauberli E., Wilson A., Mackay F., Rolink A.G., Beermann F., Tschopp J., and Schneider P. The anti-apoptotic factor Bcl-2 can functionally substitute for the B cell survival but not for the marginal zone B cell differentiation activity of BAFF. Eur. J. Immunol. 34 (2004) 509-518
41. Tian B., Nowak D.E., Jamaluddin M., Wang S., and Brasier A.R. Identification of direct genomic targets downstream of the nuclear factor-kappaB transcription factor mediating tumor necrosis factor signaling. J. Biol. Chem. 280 (2005) 17435-17448
42. Tinnell S.B., Jacobs-Helber S.M., Sterneck E., Sawyer S.T., and Conrad D.H. STAT6, NF-kappaB and C/EBP in CD23 expression and IgE production. Int. Immunol. 10 (1998) 1529-1538
43. Verkoczy L., Ait-Azzouzene D., Skog P., Martensson A., Lang J., Duong B., and Nemazee D. A role for nuclear factor kappa B/rel transcription factors in the regulation of the recombinase activator genes. Immunity 22 (2005) 519-531
44. Xue L., Morris S.W., Orihuela C., Tuomanen E., Cui X., Wen R., and Wang D. Defective development and function of Bcl10-deficient follicular, marginal zone and B1 B cells. Nat. Immunol. 4 (2003) 857-865
45. Yamada T., Mitani T., Yorita K., Uchida D., Matsushima A., Iwamasa K., Fujita S., and Matsumoto M. Abnormal immune function of hemopoietic cells from alymphoplasia (aly) mice, a natural strain with mutant NF-kappa B-inducing kinase. J. Immunol. 165 (2000) 804-812
46. Zambrowicz B.P., Imamoto A., Fiering S., Herzenberg L.A., Kerr W.G., and Soriano P. Disruption of overlapping transcripts in the ROSA beta geo 26 gene trap strain leads to widespread expression of beta-galactosidase in mouse embryos and hematopoietic cells. Proc. Natl. Acad. Sci. USA 94 (1997) 3789-3794